Progressive “harm reduction” advocates have insisted for decades that active users should take a central role in crafting drug policy. While this belief is profoundly reckless—akin to letting drunk ...

The same drugs that transformed obesity treatment are now being investigated for substance use disorders, fueling interest in ...

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...

Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...

For many people, the thought of a tasty burger or a cold pint of beer conjures up a vivid mental image and drives behaviour. This link between thinking and doing serves a clear function – it motivates ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...